Cargando…

Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study

BACKGROUND: Older adults are at an increased risk of delirium because of age, polypharmacy, multiple comorbidities and acute illness. Antimuscarinics are the backbone of the pharmacological management of overactive bladder. However, the safety profiles of antimuscarinics vary because of their dissim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishtala, Prasad S., Chyou, Te‐Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545361/ https://www.ncbi.nlm.nih.gov/pubmed/35587029 http://dx.doi.org/10.1002/pds.5480

Ejemplares similares

Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system
por: Chinzowu, Tichawona, et al.
Publicado: (2022)

Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2016)

Treatment of pediatric antimuscarinic delirium with oral rivastigmine
por: Yakey, Brandtly, et al.
Publicado: (2023)

Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
por: Nishtala, Prasad S., et al.
Publicado: (2019)

Use of Antimuscarinics in the Elderly
por: Patel, Bhavin, et al.
Publicado: (2009)

Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis
por: Chinzowu, Tichawona, et al.
Publicado: (2021)

Use of bladder antimuscarinics is associated with an increased risk of dementia: a retrospective population-based case–control study
por: Harnod, Tomor, et al.
Publicado: (2021)

High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatment
por: Liao, Chun-Hou, et al.
Publicado: (2016)

Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
por: Chughtai, Bilal, et al.
Publicado: (2008)

Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People
por: Ndukwe, Henry C., et al.
Publicado: (2015)

Bladder antimuscarinics and cognitive decline in elderly patients
por: Moga, Daniela Claudia, et al.
Publicado: (2017)

Application of machine learning approaches in predicting clinical outcomes in older adults – a systematic review and meta-analysis
por: Olender, Robert T., et al.
Publicado: (2023)

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011)

Sleep and Delirium in Older Adults
por: Farasat, Sadaf, et al.
Publicado: (2020)

Delirium in Frail Older Adults
por: Kwak, Min Ji
Publicado: (2021)

Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia
por: Parise, Hélène, et al.
Publicado: (2019)

A Delirium Risk Stratification Tool and Interdisciplinary Rounds to Prevent Delirium in Hospitalized Older Adults
por: Woodward, Jennifer, et al.
Publicado: (2021)

Influence of current state of executive function and working memory on adherence to antimuscarinic therapy in older women with OAB
por: Kosilov, Kirill, et al.
Publicado: (2019)

Associations of Potentially Inappropriate Medicine Use with Fall-Related Hospitalisations and Primary Care Visits in Older New Zealanders: A Population-Level Study Using the Updated 2012 Beers Criteria
por: Narayan, Sujita W., et al.
Publicado: (2015)

Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer
por: Löfling, Lukas, et al.
Publicado: (2019)

Delirium markers in older fallers: a case-control study
por: Doherty, Kelly, et al.
Publicado: (2014)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine
por: Howell, G, et al.
Publicado: (2005)

Hospital-Associated Disability Associated With Delirium Among Older Adults
por: Kennedy, Richard, et al.
Publicado: (2021)

Hospital-Associated Disability Associated With Delirium Among Older Adults
por: Kennedy, Richard, et al.
Publicado: (2021)

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors
por: Kosilov, Kirill Vladimirovich, et al.
Publicado: (2017)

Emergency Department Length of Stay Is Associated with Delirium in Older Adults
por: Elder, Natalie M, et al.
Publicado: (2023)

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK
por: Nazir, Jameel, et al.
Publicado: (2017)

Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data
por: Andretta, Elena, et al.
Publicado: (2022)

Vitamin D and Delirium in Older Adults: A Case-Control Study in Geriatric Acute Care Unit
por: Chouët, Justine, et al.
Publicado: (2020)

Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
por: Kim, Aram, et al.
Publicado: (2017)

The Influence of Patient Characteristics on Anticholinergic Events in Older People
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2016)

Frailty, delirium and hospital mortality of older adults admitted to intensive care: the Delirium (Deli) in ICU study
por: Sanchez, David, et al.
Publicado: (2020)

Association of Poor Sleep Burden in Middle Age and Older Adults With Risk for Delirium During Hospitalization
por: Ulsa, Ma Cherrysse, et al.
Publicado: (2021)

Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder
por: Su, Shunye, et al.
Publicado: (2021)

Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study
por: Arana, Alejandro, et al.
Publicado: (2018)

Association of CSF Alzheimer's disease biomarkers with postoperative delirium in older adults
por: Fong, Tamara G., et al.
Publicado: (2021)

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder
por: Lee, Soyon, et al.
Publicado: (2009)

Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of In Vivo Drug-Receptor Binding
por: Yamada, Shizuo, et al.
Publicado: (2012)

Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies
por: Mendoza, Fabian A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vi34mctubng2p1pqrvp4dnvt92